BRAINCOOL Image
IMAGE FULLERYOUTHINSTITUTE.COM

BRAINCOOL

MARKET CAP - 259M SEK
MARKET CAP - 259M SEK

ABOUT US

BrainCool started as a subsidiary of Dignitana AB (publ), on quest of targeting the stroke market of medical cooling, so called therapeutic hypothermia. BrainCool was spun off from Dignitana and became publicly listed in 2014. Since the spinoff, the company has grown from 3 employees with focus on one medical indication, into 15 employees including operations in the US while targeting stroke, cardiac arrest, oncology, migraine, and traumatic brain injury (including a sportsmedicine division which itself is being spun off in October 2018).

Q&A WITH MARTIN WALEIJ  

Right arrow

What have been the milestones so far in your company development?

Awaiting.

Right arrow

What are your most important markets, segments and customers?

Awaiting.

Right arrow

Where do you see the company five years from now?

Awaiting.

Right arrow

What are your priorities within 2020/21?

Awaiting.

Right arrow

Why should one consider adding your company into their portfolio?

Awaiting.

PRODUCTS & SERVICES

BRAINCOOL Image
BRAINCOOL Image
BRAINCOOL Image

MEDIA